2017

June 10 2017
New study shows IO Loop™ improves patient follow-up, engagement and satisfaction following treatment with TheraSphere®

London, UK, 10 June 2017 BTG plc (LSE: BTG), a global specialist healthcare company, today announced the results of a pilot study evaluating the effectiveness of a digital patient engagement...

June 07, 2017
SIO announces first grants in Interventional Oncology / Immuno-Oncology research programme

Washington, DC, 07 June 2017 The Society of Interventional Oncology (SIO), a global organization working to nurture and support interventional oncology worldwide, and global specialist healthcare...

May 22 2017
OPTALYSE PE Study Demonstrates Safety and Efficacy of Shorter, Lower Dose EKOS® Therapy For Pulmonary Embolism

Bothell, Washington, 22 May 2017 BTG plc (LSE: BTG), the global specialist healthcare company, today highlights the results of the OPTALYSE PE trial, presented at the American Thoracic Society...

May 19, 2017
BTG and HealthLoop collaborate on IO Loop™, an exclusive service to connect patients and interventional oncologists throughout treatment

#, 19 May 2017 Data from a pilot study using IO Loop™ with TheraSphere® (a Y90 transarterial radioembolisation therapy) will be presented at the World Conference on Interventional Oncology BTG...

May 16, 2017
BTG plc: Final Results 2017

London, UK, 16 May 2017 BTG plc (LSE: BTG), the global specialist healthcare company, today announces its final results for the year ended 31 March 2017. Click here to download the results release...

Show per page

Top